Suchergebnisse - "Alzheimer Disease diagnosis"

Contactin proteins in cerebrospinal fluid show different alterations in dementias

Autoren: Besnik Muqaku Sarah Anderl-Straub Leonie Werner et al.

Quelle: J Neurol
Journal of neurology 271(12), 7516-7524 (2024). doi:10.1007/s00415-024-12694-6

Schlagwörter: Male, Lewy Body Disease, Synaptic dysfunction, cerebrospinal fluid [Lewy Body Disease], cerebrospinal fluid [Frontotemporal Dementia], Mass Spectrometry, cerebrospinal fluid [Contactins], diagnosis [Frontotemporal Dementia], Contactins, Alzheimer Disease, cerebrospinal fluid [Parkinson Disease], Contactin, Humans, ddc:610, Aged, Aged, 80 and over, Original Communication, cerebrospinal fluid [Dementia], diagnosis [Alzheimer Disease], Parkinson Disease, Biomarker, Middle Aged, Aged, 80 and over [MeSH], Aged [MeSH], Lewy Body Disease/cerebrospinal fluid [MeSH], Lewy Body Disease/diagnosis [MeSH], Dementia/diagnosis [MeSH], Cerebrospinal fluid, Frontotemporal Dementia/diagnosis [MeSH], Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Frontotemporal Dementia/cerebrospinal fluid [MeSH], Mass Spectrometry [MeSH], Dementia, Female [MeSH], Humans [MeSH], Dementia/cerebrospinal fluid [MeSH], Middle Aged [MeSH], Parkinson Disease/diagnosis [MeSH], Biomarkers/cerebrospinal fluid [MeSH], Contactins/cerebrospinal fluid [MeSH], Parkinson Disease/cerebrospinal fluid [MeSH], Alzheimer Disease/cerebrospinal fluid [MeSH], diagnosis [Dementia], cerebrospinal fluid [Alzheimer Disease], cerebrospinal fluid [Biomarkers], Frontotemporal Dementia, Female, diagnosis [Lewy Body Disease], diagnosis [Parkinson Disease], Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39317877
https://pure.amsterdamumc.nl/en/publications/7b035f3c-0ba0-49a7-bd8c-5799d4d0172b
https://doi.org/10.1007/s00415-024-12694-6
https://repository.publisso.de/resource/frl:6521897

Blood‐based multivariate methylation risk score for cognitive impairment and dementia

Autoren: Alzheimer's Disease Neuroimaging Initiative Koetsier, Jarno Cavill, Rachel et al.

Weitere Verfasser: Alzheimer's Disease Neuroimaging Initiative Koetsier, Jarno Cavill, Rachel et al.

Quelle: Alzheimers Dement
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Alzheimer's & dementia, vol. 20, no. 10, pp. 6682-6698
Alzheimer's & dementia

Schlagwörter: Male, Aging, Parkinson's disease, mild cognitive impairments, Cognitive Dysfunction/genetics, Machine Learning, risk prediction, Risk Factors, Humans, DNA Methylation/genetics, Cognitive Dysfunction/blood, Cognitive Dysfunction/diagnosis, Female, Aged, Dementia/genetics, Dementia/blood, Dementia/diagnosis, Cross-Sectional Studies, Alzheimer Disease/genetics, Alzheimer Disease/blood, Alzheimer Disease/diagnosis, Prospective Studies, Risk Assessment, Aged, 80 and over, Alzheimer's disease, DNA methylation, aging, dementia, epigenetics, machine learning, risk factors, risk assessment, Risk prediction, 3. Good health, [SDV] Life Sciences [q-bio], ALZHEIMERS-DISEASE, INSIGHTS, Mild cognitive impairments, Epigenetics, Life Sciences & Biomedicine, Neurovetenskaper, PACKAGE, Research Article, Clinical Neurology, Alzheimer Disease, Machine learning, Cognitive Dysfunction, Science & Technology, Neurosciences, Alzheimer's Disease Neuroimaging Initiative, 3202 Clinical sciences, 1103 Clinical Sciences, DNA Methylation, LIFE, Geriatrics, 5202 Biological psychology, 3209 Neurosciences, Dementia, Human medicine, Neurosciences & Neurology, aged, 80 and over, 1109 Neurosciences, TASK-FORCE

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39193899
https://ora.ox.ac.uk/objects/uuid:08a486db-1f7f-4b35-b6a2-33530660f081
https://doi.org/10.1002/alz.14061
https://lirias.kuleuven.be/handle/20.500.12942/753328
https://doi.org/10.1002/alz.14061
https://ddd.uab.cat/record/309035
https://serval.unil.ch/notice/serval:BIB_A14021C3A90F
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A14021C3A90F8
https://serval.unil.ch/resource/serval:BIB_A14021C3A90F.P001/REF.pdf
https://repository.uantwerpen.be/docstore/d:irua:25714
https://hdl.handle.net/10067/2087890151162165141
https://biblio.vub.ac.be/vubir/bloodbased-multivariate-methylation-risk-score-for-cognitive-impairment-and-dementia(90ab5aa5-d13c-4ada-94f7-b19b56b13c69).html
https://hal.univ-lille.fr/hal-04977598v1/document
https://doi.org/10.1002/alz.14061
https://hal.univ-lille.fr/hal-04977598v1
http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-115682

Independent validation and outlier analysis of EuroPOND Alzheimer’s disease staging model using ADNI and real-world clinical data

Autoren: Wittens, Mandy M J Sima, Diana M Brys, Arne et al.

Weitere Verfasser: Wittens, Mandy M J Sima, Diana M Brys, Arne et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 17, Iss 1, Pp 1-15 (2025)
Alzheimer's Research & Therapy, Vol. 17, no.1 (2025)
Alzheimer's research & therapy

Schlagwörter: Male, Sciences sociales & comportementales, psychologie, Neuropsychological Tests, Alzheimer Disease/cerebrospinal fluid, Cohort Studies, Alzheimer Disease/pathology, Neurosciences & comportement, 11 Medical and Health Sciences, AMYLOID-PET, Aged, 80 and over, DEMENTIA, Alzheimer's disease, Middle Aged, Mental Status and Dementia Tests, Magnetic Resonance Imaging, MENTAL-STATE-EXAMINATION, Disease Progression, Female, Life Sciences & Biomedicine, RC321-571, Alzheimer Disease/diagnosis, Alzheimer Disease/diagnostic imaging, BIOMARKERS, Clinical Neurology, tau Proteins, Neurosciences. Biological psychiatry. Neuropsychiatry, Cognitive Dysfunction/cerebrospinal fluid, Magnetic resonance imaging, Alzheimer Disease, Humans, Event-based modelling, Biomarkers/cerebrospinal fluid, Cognitive Dysfunction, RC346-429, Aged, Science & Technology, Amyloid beta-Peptides, 42 Health sciences, Neurosciences & behavior, Research, Neurosciences, tau Proteins/cerebrospinal fluid, 32 Biomedical and clinical sciences, Amyloid beta-Peptides/cerebrospinal fluid, HYPOTHETICAL MODEL, Automated volumetry, Social & behavioral sciences, psychology, Human medicine, Neurosciences & Neurology, Neurology. Diseases of the nervous system, Biomarkers

Zugangs-URL: https://doaj.org/article/4ac244a8e3514ea89eac381bed6bba63
https://lirias.kuleuven.be/handle/20.500.12942/769282
https://doi.org/10.1186/s13195-025-01788-6
https://hdl.handle.net/2268/333357
https://doi.org/10.1186/s13195-025-01788-6
https://hdl.handle.net/2078.1/303503
https://hdl.handle.net/10067/2152550151162165141
https://repository.uantwerpen.be/docstore/d:irua:29598

Visuospatial impairment in dementia: a new index to improve the clinical diagnosis of Alzheimer’s disease

Autoren: Francesca Santagata Stefano F. Cappa Roberto Presta et al.

Quelle: Aging Clin Exp Res
Aging clinical and experimental research, vol. 37, no. 1, pp. 127

Schlagwörter: Male, Aged, 80 and over, Research, Neuropsychological Tests, Middle Aged, Diagnosis, Differential, Humans, Alzheimer Disease/diagnosis, Alzheimer Disease/psychology, Female, Aged, Retrospective Studies, Cognitive Dysfunction/diagnosis, Dementia/diagnosis, Space Perception, Alzheimer's disease, Dementia, Neuropsychological assessment, Visuospatial function, Alzheimer Disease, Cognitive Dysfunction

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40249550
https://serval.unil.ch/notice/serval:BIB_F1F1CE649A35
https://serval.unil.ch/resource/serval:BIB_F1F1CE649A35.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F1F1CE649A357

Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases

Autoren: Janbek, Janet Laursen, Thomas Munk Frimodt-Møller, Niels et al.

Quelle: J Alzheimers Dis
Janbek, J, Laursen, T M, Frimodt-Møller, N, Magyari, M, Haas, J G, Lathe, R & Waldemar, G 2024, ' Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases ', Journal of Alzheimer's Disease, vol. 98, no. 4, pp. 1503-1514 . https://doi.org/10.3233/JAD-231349
Janbek, J, Laursen, T M, Frimodt-Møller, N, Magyari, M, Haas, J G, Lathe, R & Waldemar, G 2024, 'Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases', Journal of Alzheimer's Disease, vol. 98, no. 4, pp. 1503-1514. https://doi.org/10.3233/JAD-231349

Schlagwörter: Alzheimer Disease/diagnosis, immunosenescence, 0301 basic medicine, Dementia, Vascular, autoimmune disease, vascular dementia, infection, Hospitals, population-based, Autoimmune Diseases, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Autoimmune Diseases/epidemiology, Alzheimer Disease, Case-Control Studies, Humans, epidemiology, reverse causality, Alzheimer's disease, Research Article

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38640163
https://curis.ku.dk/ws/files/392571985/jad_2024_98_4_jad_98_4_jad231349_jad_98_jad231349.pdf
https://pure.au.dk/portal/en/publications/7f019e9c-4440-4fdd-bd39-30952314bbc3
https://doi.org/10.3233/JAD-231349
http://www.scopus.com/inward/record.url?scp=85191105249&partnerID=8YFLogxK

RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer’s disease: assessment of multiple remote monitoring technologies for early detection of Alzheimer's disease

Autoren: Manuel Lentzen Srinivasan Vairavan Marijn Muurling et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 17, Iss 1, Pp 1-17 (2025)

Schlagwörter: Alzheimer Disease/diagnosis, Male, Aged, 80 and over, Wearables, Research, Remote Sensing Technology/methods instrumentation, Neurosciences. Biological psychiatry. Neuropsychiatry, Remote monitoring technologies, Middle Aged, Neuropsychological Tests, Machine Learning, Early Diagnosis, Mobile applications, Alzheimer Disease, 80 and over, Humans, Female, Neurology. Diseases of the nervous system, Discriminative capacity, RC346-429, Alzheimer's disease, RC321-571, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39865315
https://doaj.org/article/789e135650fb424787d398f5a39e039d
https://cris.maastrichtuniversity.nl/en/publications/1859aac6-e194-408b-9692-de2c56d4d7ba
https://doi.org/10.1186/s13195-025-01675-0
https://pure.amsterdamumc.nl/en/publications/4d72b938-9b0d-4871-8d81-6063b0f680d3
https://doi.org/10.1186/s13195-025-01675-0
https://ora.ox.ac.uk/objects/uuid:eb08b97b-b5b6-427a-8c10-1dc7f22546db
https://doi.org/10.1186/s13195-025-01675-0

European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders

Autoren: Frisoni G. B. Festari C. Massa F. et al.

Quelle: Frisoni, G B, Festari, C, Massa, F, Cotta Ramusino, M, Orini, S, Aarsland, D, Agosta, F, Babiloni, C, Borroni, B, Cappa, S F, Frederiksen, K S, Froelich, L, Garibotto, V, Haliassos, A, Jessen, F, Kamondi, A, Kessels, R P C, Morbelli, S D, O'Brien, J T, Otto, M, Perret-Liaudet, A, Pizzini, F B, Vandenbulcke, M, Vanninen, R, Verhey, F, Vernooij, M W, Yousry, T, Boada Rovira, M, Dubois, B, Georges, J, Hansson, O, Ritchie, C W, Scheltens, P, van der Flier, W M & Nobili, F 2024, 'European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders', The Lancet Neurology, vol. 23, no. 3, pp. 302-312. https://doi.org/10.1016/S1474-4422(23)00447-7
The lancet 23(3), 302-312 (2024). doi:10.1016/S1474-4422(23)00447-7
Lancet Neurology, 23, 3, pp. 302-312

Schlagwörter: Societies, Scientific, Neuro- en revalidatiepsychologie, Consensus, 616.0757, Alzheimer Disease / diagnosis, DEMENTIA, Neuropsychology and rehabilitation psychology, VARIANT, diagnosis [Alzheimer Disease], COGNITIVE IMPAIRMENT, GUIDELINES, mild cognitive impairment, mci, dementia with lewy bodies, dlb, frontotemporal dementia, ftd, Alzheimer Disease, Biomarkers, Europe, Humans, CLASSIFICATION, 3. Good health, ALZHEIMERS-DISEASE, 618.97, MANAGEMENT, CRITERIA, ddc:610, EEG

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38365381
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/303576
https://doi.org/10.1016/S1474-4422(23)00447-7
https://cris.maastrichtuniversity.nl/en/publications/14051442-cc00-4bdd-b059-7c8ed052fc4a
https://doi.org/10.1016/S1474-4422(23)00447-7
https://research.vumc.nl/en/publications/8d823ffc-3c9f-48eb-9297-85a6f4a88dd8
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00447-7/abstract
https://hdl.handle.net/20.500.11768/160779
https://doi.org/10.1016/S1474-4422(23)00447-7
https://repository.ubn.ru.nl//bitstream/handle/2066/303576/303576.pdf
https://hdl.handle.net/2066/303576
https://archive-ouverte.unige.ch/unige:177261
https://doi.org/10.1016/s1474-4422(23)00447-7
https://hdl.handle.net/11562/1119674
https://doi.org/10.1016/S1474-4422(23)00447-7
https://hdl.handle.net/11573/1704231
https://doi.org/10.1016/S1474-4422(23)00447-7
https://hdl.handle.net/11567/1205117
https://doi.org/10.1016/S1474-4422(23)00447-7

Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease

Autoren: Qingfeng Wen Mandy Melissa Jane Wittens Sebastiaan Engelborghs et al.

Weitere Verfasser: Qingfeng Wen Mandy Melissa Jane Wittens Sebastiaan Engelborghs et al.

Quelle: ACS Chem Neurosci
ACS chemical neuroscience

Schlagwörter: Alzheimer Disease/diagnosis, 2. Zero hunger, Amyloid beta-Peptides, Cognitive Dysfunction/diagnosis, biomarkers, Neuroimaging, tau Proteins, miR-145, microRNAs, 3. Good health, Chemistry, Phosphatidylinositol 3-Kinases, MicroRNAs, Alzheimer Disease, Humans, Cognitive Dysfunction, Human medicine, PI3K/AKT signaling, Biology, Alzheimer's disease, Biomarkers

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38407050
https://cris.maastrichtuniversity.nl/en/publications/a26f4577-8e2b-4ffc-a551-7722cf3355b8
https://doi.org/10.1021/acschemneuro.3c00740
https://hdl.handle.net/10067/2048220151162165141
https://repository.uantwerpen.be/docstore/d:irua:22763
https://biblio.vub.ac.be/vubir/(1d8416b2-28cc-4886-81f8-ae6c496fdddd).html

Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease

Autoren: Damsgaard, Line Janbek, Janet Laursen, Thomas M. et al.

Quelle: Alzheimers Dement
Damsgaard, L, Janbek, J, Laursen, T M, Høgh, P, Vestergaard, K, Gottrup, H, Jensen-Dahm, C & Waldemar, G 2024, 'Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease', Alzheimer's & Dementia, vol. 20, no. 4, pp. 2373-2383. https://doi.org/10.1002/alz.13681
Damsgaard, L, Janbek, J, Laursen, T M, Høgh, P, Vestergaard, K, Gottrup, H, Jensen-Dahm, C & Waldemar, G 2024, ' Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease ', Alzheimer's & Dementia, vol. 20, no. 4, pp. 2373-2383 . https://doi.org/10.1002/alz.13681
Damsgaard, L, Janbek, J, Laursen, T M, Høgh, P, Vestergaard, K, Gottrup, H, Jensen-Dahm, C & Waldemar, G 2024, 'Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease', Alzheimer's & dementia : the journal of the Alzheimer's Association, vol. 20, no. 4, pp. 2373-2383. https://doi.org/10.1002/alz.13681

Schlagwörter: Alzheimer Disease/diagnosis, young onset dementia, early warning signs, morbidity, Alzheimer's disease, registry-based, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Case-Control Studies, Humans, epidemiology, Morbidity, Research Articles, Retrospective Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38294143
https://vbn.aau.dk/ws/files/703649636/Damsgaard_et_al._2024_._Mapping_morbidity_10_years_prior_to_a_diagnosis_of_young_onset_Alzheimer_s_disease.pdf
http://www.scopus.com/inward/record.url?scp=85183866365&partnerID=8YFLogxK
https://doi.org/10.1002/alz.13681
https://vbn.aau.dk/da/publications/a7dfa993-512b-4839-86eb-d1b83e55ccb0
https://curis.ku.dk/ws/files/391884850/Alzheimer_s_Dementia_2024_Damsgaard_Mapping_morbidity_10_years_prior_to_a_diagnosis_of_young_onset_Alzheimer_s.pdf
http://www.scopus.com/inward/record.url?scp=85183866365&partnerID=8YFLogxK
https://doi.org/10.1002/alz.13681
https://pure.au.dk/portal/en/publications/cad6bdaa-d899-4468-9614-c1de7db405d5

Maladie d’Alzheimer: ce qui a changé en 2023

Autoren: Donayre, Dylan Graf, Christophe Frisoni, Giovanni et al.

Quelle: Revue Médicale Suisse. 20:51-54

Schlagwörter: Europe, 618.97, Alzheimer Disease / diagnosis, Disease Progression, Humans, Alzheimer Disease / drug therapy, Alzheimer Disease / epidemiology, 3. Good health

Dateibeschreibung: application/pdf

Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 1: Klinik und Diagnostik

Autoren: Dodel, Richard Berg, Daniela Duning, Thomas et al.

Quelle: Nervenarzt

Schlagwörter: Übersichten, Medizin, Genetik, Cerebral imaging, Lewy Body Disease/diagnosis [MeSH], Dementia/etiology [MeSH], Humans [MeSH], Parkinson's disease with dementia, Parkinson-Krankheit mit Demenz, Zerebrale Bildverarbeitung, Parkinson Disease/diagnosis [MeSH], Alzheimer Disease/diagnosis [MeSH], Epidemiology, Lewy Body Disease/complications [MeSH], Genetics, Quality of Life [MeSH], Epidemiologie, Neuropsychologie, Lewy Body Disease/therapy [MeSH]

Zugangs-URL: https://repository.publisso.de/resource/frl:6514286
https://www.ncbi.nlm.nih.gov/pubmed/38092983
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85179662665
https://doi.org/10.1007/s00115-023-01576-3

Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia

Autoren: Axelsson Andrén, Elin Kettunen, Petronella Bjerke, Maria et al.

Weitere Verfasser: Axelsson Andrén, Elin Kettunen, Petronella Bjerke, Maria et al.

Quelle: J Alzheimers Dis
Journal of Alzheimer's disease
Journal of Alzheimer's Disease

Schlagwörter: Alzheimer Disease/diagnosis, intermediate filaments, Amyloid beta-Peptides, Intermediate Filaments, tau Proteins/cerebrospinal fluid, tau Proteins, Amyloid beta-Peptides/cerebrospinal fluid, 3. Good health, Amyloid beta-Protein Precursor, Amyloid beta-Protein Precursor/cerebrospinal fluid, Dementia/diagnosis, Neurofilament Proteins/cerebrospinal fluid, Alzheimer Disease, Neurofilament Proteins, Humans, Biomarkers/cerebrospinal fluid, Dementia, Human medicine, Mixed Dementias, Biomarkers, Research Article

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37980667
https://hdl.handle.net/10067/2038880151162165141
https://repository.uantwerpen.be/docstore/d:irua:22335

Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: Case Report and Review of the Literature

Autoren: Verde, Federico Aiello, Edoardo Nicolò Adobbati, Laura et al.

Quelle: Journal of Alzheimer's Disease. 95:1383-1399

Schlagwörter: Male, Frontotemporal Dementia / genetics, Amyotrophic Lateral Sclerosis / genetics, Alzheimer Disease / diagnosis, Frontotemporal Dementia / complications, Brain / diagnostic imaging, Amyotrophic lateral sclerosis, Alzheimer's disease, amyotrophic lateral sclerosis, neurodegeneration, neuropsychology, 3. Good health, Amyotrophic Lateral Sclerosis / complications, 618.97, Cognitive Dysfunction / complications, Neuropsychology, Humans, Female, Neurodegeneration, Amyotrophic Lateral Sclerosis / diagnosis, Alzheimer Disease / diagnostic imaging, Frontotemporal Dementia / diagnostic imaging

Dateibeschreibung: application/pdf

Zugangs-URL: https://hdl.handle.net/2434/1032037
https://doi.org/10.3233/jad-230562
https://hdl.handle.net/10281/520836
https://doi.org/10.3233/JAD-230562
https://archive-ouverte.unige.ch/unige:177099
https://doi.org/10.3233/jad-230562

A systematic review on recent methods on deep learning for automatic detection of Alzheimer's disease

Autoren: Radhakrishna Chamakuri Hyma Janapana

Quelle: Medicine in Novel Technology and Devices, Vol 25, Iss , Pp 100343- (2025)

Schlagwörter: Alzheimer disease diagnosis, Artificial intelligence, Deep learning, Ensemble learning, Machine learning, Medical technology, R855-855.5

Dateibeschreibung: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2590093524000596; https://doaj.org/toc/2590-0935

Zugangs-URL: https://doaj.org/article/a527ad60cfd842c88d4345c844405b6f

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis:Scoping Review

Autoren: de Rijke, Tanja J. Engelsma, Thomas Ng, Chi Him et al.

Quelle: de Rijke, T J, Engelsma, T, Ng, C H, Kaijser, K K M, Nap, H H, Smets, E M A & Visser, L N C 2025, 'Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis : Scoping Review', Journal of Medical Internet Research, vol. 27, e64862. https://doi.org/10.2196/64862

Schlagwörter: brain health, digital tools, diversity, eHealth, electronic health, equity, future directions, impact evaluation, implementation, mHealth, mobile health, stage of maturity, Humans, Alzheimer Disease/diagnosis, Dementia/diagnosis

Dateibeschreibung: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/40854181; info:eu-repo/semantics/altIdentifier/pissn/1438-8871

Verfügbarkeit: https://research.tue.nl/en/publications/0463665d-083e-48c4-b1c3-9c5a2779b590
https://doi.org/10.2196/64862
https://pure.tue.nl/ws/files/366051432/jmir-2025-1-e64862.pdf
https://www.scopus.com/pages/publications/105013960834

Changing definitions of disease:Transformations in the diagnostic criteria for Alzheimer's disease

Autoren: van der Molen, Lennart H Boenink, Marianne van Lente, Harro et al.

Quelle: van der Molen, L H, Boenink, M, van Lente, H & Richard, E 2025, 'Changing definitions of disease : Transformations in the diagnostic criteria for Alzheimer's disease', Alzheimer's & Dementia, vol. 21, no. 4, e70133, pp. 70133. https://doi.org/10.1002/alz.70133

Schlagwörter: Alzheimer's disease, Alzheimer's disease diagnosis, Alzheimer's disease diagnostic criteria, biomarkerization, biomarkers Alzheimer's disease, preclinical Alzheimer's disease, prodromal Alzheimer's disease, research in context, Alzheimer Disease/diagnosis, Humans, Biomarkers, Early Diagnosis, tau Proteins, Amyloid beta-Peptides

Relation: info:eu-repo/semantics/altIdentifier/pissn/1552-5260; info:eu-repo/semantics/altIdentifier/eissn/1552-5279

Verfügbarkeit: https://cris.maastrichtuniversity.nl/en/publications/349e905a-7730-46c1-87d7-c17f84b08fad
https://doi.org/10.1002/alz.70133
https://www.scopus.com/pages/publications/105002595847

The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndrome

Autoren: Xicota, Laura Dang, Lam-Ha T. Lee, Alice et al.

Quelle: EBioMedicine

Schlagwörter: Alzheimer's disease, CSF, Down syndrome, mosaicism, PET, plasma biomarkers, Down Syndrome / genetics, Down Syndrome / complications, Down Syndrome / diagnosis, Alzheimer Disease / genetics, Alzheimer Disease / blood, Alzheimer Disease / diagnosis, Alzheimer Disease / cerebrospinal fluid, Biomarkers, Amyloid beta, Peptides / cerebrospinal fluid, Amyloid beta-Peptides / blood, tau Proteins / cerebrospinal fluid, tau Proteins / genetics

Dateibeschreibung: application/pdf

Relation: https://doi.org/10.1016/j.ebiom.2024.105433; https://hdl.handle.net/20.500.12503/33045; 110

Verfügbarkeit: https://hdl.handle.net/20.500.12503/33045

Alzheimer's disease plasma biomarkers and physical functioning in a diverse sample of adults

Autoren: Knell, Gregory Hall, James R. Large, Stephanie et al.

Quelle: Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Schlagwörter: Alzheimer's disease, ethnic/racial disparities, neurodegenerative diseases, physical functioning, plasma biomarkers, Alzheimer Disease / blood, Alzheimer Disease / diagnosis, Biomarkers / blood, Amyloid beta-Peptides / blood, tau Proteins / blood

Dateibeschreibung: application/pdf

Relation: https://doi.org/10.1002/alz.14322; Knell, G., Hall, J. R., Large, S., Abdullah, L., Petersen, M., Johnson, L. A., & O'Bryant, S. E. (2025). Alzheimer's disease plasma biomarkers and physical functioning in a diverse sample of adults. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(1), e14322. https://doi.org/10.1002/alz.14322; https://hdl.handle.net/20.500.12503/33039; 21

Verfügbarkeit: https://hdl.handle.net/20.500.12503/33039

Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohort

Autoren: Giovane, Martina Del Giunchiglia, Valentina Cai, Ziyuan et al.

Quelle: Giovane, M D, Giunchiglia, V, Cai, Z, Leoni, M, Street, R, Lu, K, Wong, A, Popham, M, Nicholas, J M, Trender, W, Hellyer, P J, Parker, T D, Murray-Smith, H, Cash, D M, Barnes, J, Sudre, C H, Malhotra, P A, Crutch, S J, Richards, M, Hampshire, A & Schott, J M 2025, 'Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohort', Alzheimer's & Dementia, vol. 21, no. 2, e14572, pp. e14572. https://doi.org/10.1002/alz.14572

Schlagwörter: Humans, Male, Female, Aged, Neuropsychological Tests/statistics & numerical data, Biomarkers, Alzheimer Disease/diagnosis, Brain/pathology, Cohort Studies, Magnetic Resonance Imaging, Cognition/physiology, Hippocampus/pathology, White Matter/pathology, Atrophy/pathology, Amyloid beta-Peptides

Verfügbarkeit: https://kclpure.kcl.ac.uk/portal/en/publications/6d428e69-9880-4ebc-93e6-a01b2a395c0d
https://doi.org/10.1002/alz.14572
http://www.scopus.com/inward/record.url?scp=85218809726&partnerID=8YFLogxK

Blood-based biomarkers and plasma Aβ assays in the differential diagnosis of Alzheimer’s disease and behavioral-variant frontotemporal dementia

Autoren: Mohaupt, Pablo Kindermans, Jana Vialaret, Jérôme et al.

Quelle: Alzheimers Res Ther
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-12 (2024)
Alzheimer's research & therapy 16(1), 279 (2024). doi:10.1186/s13195-024-01647-w

Schlagwörter: blood [Frontotemporal Dementia], Male, 0301 basic medicine, blood [Neurofilament Proteins], Mass Spectrometry, diagnosis [Frontotemporal Dementia], 0302 clinical medicine, Neurofilament Proteins, blood [Amyloid beta-Peptides], blood [Glial Fibrillary Acidic Protein], Alzheimer Disease/blood [MeSH], Frontotemporal lobar degeneration, Aged, 80 and over [MeSH], Aged [MeSH], Amyloid-beta, Blood biomarker, Mass spectrometry, Frontotemporal Dementia/diagnosis [MeSH], Diagnosis, Differential [MeSH], Differential diagnosis, Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Neurofilament Proteins/blood [MeSH], Peptide Fragments/blood [MeSH], tau Proteins/blood [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Dementia, Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Glial Fibrillary Acidic Protein/blood [MeSH], Frontotemporal Dementia/blood [MeSH], Middle Aged [MeSH], Research, Mass Spectrometry/methods [MeSH], Immunoprecipitation/methods [MeSH], Amyloid beta-Peptides/blood [MeSH], Aged, 80 and over, ddc:610, blood [Biomarkers], diagnosis [Alzheimer Disease], Middle Aged, amyloid beta-protein (1-42), blood [Peptide Fragments], Frontotemporal Dementia, Female, RC321-571, blood [tau Proteins], Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, Diagnosis, Differential, 03 medical and health sciences, blood [Alzheimer Disease], Alzheimer Disease, Glial Fibrillary Acidic Protein, Humans, Immunoprecipitation, neurofilament protein L, RC346-429, Aged, Amyloid beta-Peptides, methods [Mass Spectrometry], GFAP protein, human, amyloid beta-protein (1-40), Peptide Fragments, cerebrospinal fluid [tau Proteins], Neurology. Diseases of the nervous system, Biomarkers, methods [Immunoprecipitation]

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39736793
https://doaj.org/article/8482f023cd8d414983ccd571ed1507bb
https://pub.dzne.de/record/274026
https://repository.publisso.de/resource/frl:6493458